Biliary Cholangitis
📧 Sign up to get email alerts when something new happens for Biliary Cholangitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-16Clinical Trial Results: Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC [Phase 2]
Phase 2 trial investigating obeticholic acid (OCA) in combination with BZF for efficacy, safety, and tolerability in primary biliary cholang…
-
CLINICAL_TRIALS trial_result · 2026-07-16Clinical Trial Results: Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC [Phase 2]
Phase 2 clinical trial evaluating obeticholic acid (OCA) in combination with an additional agent (BZF) for primary biliary cholangitis; stud…
-
CLINICAL_TRIALS trial_result · 2026-07-09Clinical Trial Update: A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid. [Phase 3]
Phase 3 trial update for elafibranor in adults with primary biliary cholangitis who had inadequate response or intolerance to ursodeoxycholi…
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Update: A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid. [Phase 3]
A Phase 3 clinical trial investigating elafibranor in adults with primary biliary cholangitis and inadequate response or intolerance to urso…
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Results: To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate [Phase 3]
Phase 3 trial evaluating safety and tolerability of a fixed-dose combination of obeticholic acid and bezafibrate in primary biliary cholangi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) [Phase 3]
Phase 3 trial update assessing seladelpar's effect on normalizing alkaline phosphatase in primary biliary cholangitis.
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis [Phase 2]
A Phase 2 study is evaluating the efficacy and safety of the investigational drug Volixibat for pruritus in patients with Primary Biliary Ch…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria)
Completed clinical trial update describing scratch and sleep patterns in patients with Primary Biliary Cholangitis (Luminaria), sponsored by…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis [Phase 3]
Seladelpar is being evaluated in a Phase 3 trial for primary biliary cholangitis with compensated cirrhosis and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating the safety, tolerability, pharmacodynamics, and efficacy of CNP-104 in subjects with Primary…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Biochemical Response and Clinical Outcomes in Patients With PBC
This entry notes ongoing recruitment for a study evaluating biochemical response and clinical outcomes in patients with Primary Biliary Chol…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Repeatability and Reproducibility of Multiparametric MRI
A clinical trial update reports on the repeatability and reproducibility of multiparametric MRI for evaluating liver diseases across several…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis [EARLY_Phase 1]
This clinical trial update reports the completion of a Phase 1 pilot study evaluating the combination of fenofibrate and ursodeoxycholic aci…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC) [Phase 1]
Phase 1 single ascending dose study of PVT201 in healthy subjects and patients with primary biliary cholangitis (PBC) has completed; the sni…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC [Phase 2]
Phase 2 trial evaluating the combination of obeticholic acid (OCA) and bezafibrate (BZF) for Primary Biliary Cholangitis has been terminated…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate [Phase 3]
Phase 3 trial evaluating the safety and tolerability of a fixed-dose combination of obeticholic acid and bezafibrate in primary biliary chol…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC [Phase 2]
A Phase 2 trial evaluating obeticholic acid in combination with bezafibrate for primary biliary cholangitis has completed, with results not …
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis [Phase 2]
Phase 2 clinical trial TH104 for treating pruritus in primary biliary cholangitis; status is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: TruGraf Liver Gene Expression Serial Test
The TruGraf Liver Gene Expression Serial Test is enrolling by invitation at Washington University for autoimmune liver diseases, including a…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis [Phase 2]
Phase 2 study update reporting results for EP547 in patients with cholestatic pruritus due to primary biliary cholangitis or primary scleros…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN) [Phase 3]
Phase 3 GLISTEN trial evaluating linerixibat for pruritus in primary biliary cholangitis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury [Phase 1]
A Phase 1 trial update on the pharmacokinetics and safety of the investigational drug CS0159 in subjects with hepatic injury, including thos…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in Women [NA]
A completed clinical trial from Assistance Publique - Hôpitaux de Paris evaluating psychoeducational and hypnosis interventions to reduce fa…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis [Phase 2, Phase 3]
Clinical trial update indicating completion of Phase 2 and Phase 3 studies evaluating saroglitazar magnesium for Primary Biliary Cholangitis…
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis. [Phase 1]
Phase 1 study evaluating the pharmacokinetics and safety of pemafibrate (K-808) in subjects with primary biliary cholangitis with compensate…